The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
Open accessPublished version of a preprint
Abstract
Antibiotics have revolutionized medicine, saving countless lives since their discovery in the early 20th century. However, the origin of antibiotics is now overshadowed by the alarming rise in antibiotic resistance. This global crisis stems from the relentless adaptability of microorganisms, driven by misuse and overuse of antibiotics. This article explores the origin of antibiotics and the subsequent emergence of antibiotic resistance. It delves into the mechanisms employed by bacteria to develop resistance, highlighting the dire consequences of drug resistance, including compromised patient care, increased mortality rates, and escalating healthcare costs. The article elucidates the latest strategies against drug-resistant microorganisms, encompassing innovative approaches such as phage therapy, CRISPR-Cas9 technology, and the exploration of natural compounds. Moreover, it examines the profound impact of antibiotic resistance on drug development, rendering the pursuit of new antibiotics economically challenging. The limitations and challenges in developing novel antibiotics are discussed, along with hurdles in the regulatory process that hinder progress in this critical field. Proposals for modifying the regulatory process to facilitate antibiotic development are presented. The withdrawal of major pharmaceutical firms from antibiotic research is examined, along with potential strategies to re-engage their interest. The article also outlines initiatives to overcome economic challenges and incentivize antibiotic development, emphasizing international collaborations and partnerships. Finally, the article sheds light on government-led initiatives against antibiotic resistance, with a specific focus on the Middle East. It discusses the proactive measures taken by governments in the region, such as Saudi Arabia and the United Arab Emirates, to combat this global threat. In the face of antibiotic resistance, a multifaceted approach is imperative. This article provides valuable insights into the complex landscape of antibiotic development, regulatory challenges, and collaborative efforts required to ensure a future where antibiotics remain effective tools in safeguarding public health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–243 of 243
Zeman, M., Mašlaňová, I., Indráková, A., Šiborová, M., Mikulášek, K., Bendíčková, K., Plevka, P., Vrbovská, V., Zdráhal, Z., Doškař, J., et al. (2017) · Scientific Reports · doi:10.1038/srep46319 · Cited by 51
Górgolas, M., Avilés, P., Verdejo, C., & Guerrero, M. L. F. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.953 · Cited by 50
How Can Multi-Professional Education Support Better Stewardship?
Rocha-Pereira, N., Castro‐Sánchez, E., & Nathwani, D. (2017) · Infectious Disease Reports · doi:10.4081/idr.2017.6917 · Cited by 48
Development and Research Progress of Anti-Drug Resistant Bacteria Drugs
Cui, X., Lü, Y., & Yue, C. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s338987 · Cited by 48
Gupta, E., Saxena, J., Kumar, S., Sharma, U., Rastogi, S., Srivastava, V. K., Kaushik, S., & Jyoti, A. (2023) · Diagnostics · doi:10.3390/diagnostics13020277 · Cited by 47
Hart, A. J., Warren, J., Wilkinson, H., & Schmidt, W. (2023) · Eurosurveillance · doi:10.2807/1560-7917.es.2023.28.11.2200367 · Cited by 46
Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate
Kajihara, K. K., Pantua, H., Hernández-Barry, H., Hazen, M., Deshmukh, K., Chiang, N., Ohri, R. V., Castellanos, E. R., Martin, L., Matsumoto, M. L., et al. (2021) · mBio · doi:10.1128/mbio.00202-21 · Cited by 45
Paving the way for precise diagnostics of antimicrobial resistant bacteria
Wang, H., Jia, C., Li, H., Yin, R., Chen, J., Li, Y., & Yue, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.976705 · Cited by 45
Khan, A. U., & Rehman, M. T. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01194-15 · Cited by 44
Self-citationCombating antibiotic resistance, mitigating future threats and ongoing initiatives
Velez, R., & Sloand, E. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13246 · Cited by 43
Zulak, K. G., Cox, B. A., Tucker, M. A., Oliver, R. P., & López-Ruiz, F. J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00706 · Cited by 39
Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin
Eraikhuemen, N., Julien, D., Kelly, A., Lindsay, T., & Lazaridis, D. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00378-3 · Cited by 39
An Overview of Cefiderocol’s Therapeutic Potential and Underlying Resistance Mechanisms
Domingues, S., Lima, T., Saavedra, M. J., & Silva, G. (2023) · Life · doi:10.3390/life13071427 · Cited by 38
Balasegaram, M., & Piddock, L. J. V. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00101 · Cited by 37
Colson, A. R., Morton, A., Årdal, C., Chalkidou, K., Davies, S. C., Garrison, L. P., Jit, M., Laxminarayan, R., Megiddo, I., Morel, C. M., et al. (2021) · Value in Health · doi:10.1016/j.jval.2021.06.002 · Cited by 35
Jacobsson, S., Golparian, D., Oxelbark, J., Franceschi, F. J., Brown, D. L., Louie, A., Drusano, G. L., & Unemo, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.874176 · Cited by 35
Artificial Intelligence to Improve Antibiotic Prescribing: A Systematic Review
Amin, D., Garzόn-Orjuela, N., Garcia Pereira, A., Parveen, S., Vornhagen, H., & Vellinga, A. (2023) · Antibiotics · doi:10.3390/antibiotics12081293 · Cited by 34
Lio, R. M. S., Barchitta, M., Maugeri, A., Rosa, M. C. L., Favara, G., & Agodi, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1240584 · Cited by 34
Raz, A., Serrano, A., Lawson, C., Thaker, M., Alston, T., Bournazos, S., Ravetch, J. V., & Fischetti, V. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619249114 · Cited by 33
Exploring the One Health Perspective in Sweden’s Policies for Containing Antibiotic Resistance
Eriksen, J., Björkman, I. K., Röing, M., Essack, S. Y., & Lundborg, C. S. (2021) · Antibiotics · doi:10.3390/antibiotics10050526 · Cited by 32
Kim, J., Park, H., Ryu, S., & Jeon, B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.699630 · Cited by 32
Orfali, R. S., Perveen, S., Alajmi, M. F., Ghaffar, S., Rehman, M. T., Alanzi, A. R., Gamea, S. B., & Khwayri, M. E. (2022) · Molecules · doi:10.3390/molecules27113630 · Cited by 30
Self-citationPapadimou, D., Malmqvist, E., & Ancillotti, M. (2022) · BMC Public Health · doi:10.1186/s12889-022-13855-w · Cited by 30
Rehman, M. T., Faheem, M., & Khan, A. U. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2014.899925 · Cited by 29
Self-citationBranco, P., Maurício, E. M., Costa, A. C., Ventura, D., Roma‐Rodrigues, C., Duarte, M. P., Fernandes, A. R., & Prista, C. (2023) · Antibiotics · doi:10.3390/antibiotics12081332 · Cited by 28
The Emerging Role of Telehealth in Antimicrobial Stewardship: A Systematic Review and Perspective
Pierce, J. W., & Stevens, M. (2021) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-021-00256-7 · Cited by 27
Muteeb, G., Alsultan, A. A., Farhan, M., & Aatif, M. (2022) · Molecules · doi:10.3390/molecules27041283 · Cited by 26
Self-citationAntimicrobial resistance surveillance system mapping in different countries
Pandey, R. P., Mukherjee, R., & Chang, C.-M. (2022) · Drug Target Insights · doi:10.33393/dti.2022.2482 · Cited by 26
Muteeb, G., Rehman, M. T., Ali, S., Al-Shahrani, A., Kamal, M. A., & Ashraf, G. M. (2017) · Current Drug Metabolism · doi:10.2174/1389200217666160727100434 · Cited by 25
Self-citationLiu, B., Park, S., Thompson, C. D., Li, X., & Lee, J. C. (2016) · Virulence · doi:10.1080/21505594.2016.1270494 · Cited by 22
Characterisation of antimicrobial usage in Danish pigs in 2020
Moura, P., Sandberg, M., Høg, B. B., Niza‐Ribeiro, J., Nielsen, E. O., & Alban, L. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1155811 · Cited by 22
Kato, H., Hagihara, M., Asai, N., Umemura, T., Shibata, Y., Hirai, J., Yamagishi, Y., Iwamoto, T., & Mikamo, H. (2022) · Antibiotics · doi:10.3390/antibiotics11060719 · Cited by 21
Katale, B. Z., Mbugi, E. V., Keyyu, J. D., Fyumagwa, R., Rweyemamu, M. M., van Helden, P. D., Dockrell, H. M., & Matee, M. I. (2019) · One Health Outlook · doi:10.1186/s42522-019-0002-1 · Cited by 15
Clostridium difficile and Antibiotic-associated Diarrhea
Bhattacharyya, M., Debnath, A. K., & Todi, S. K. (2020) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23619 · Cited by 15
Nomura, S., Hanaki, H., & Nagayama, A. (1997) · Journal of Chemotherapy · doi:10.1179/joc.1997.9.2.89 · Cited by 14
Production loss and sick leave caused by antibiotic resistance: a register-based cohort study
Larsson, S., Svensson, M., & Ternhag, A. (2022) · BMC Public Health · doi:10.1186/s12889-022-12947-x · Cited by 14
Kazerooni, P. A., Nejat, M., Akbarpoor, M. A., Sedaghat, Z., & Fararouei, M. (2019) · Public Health · doi:10.1016/j.puhe.2019.03.008 · Cited by 13
Kållberg, C., Mathiesen, L., Gopinathan, U., et al. (2023) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-023-00556-x · Cited by 13
“The Chennai declaration” - Indian doctors’ fight against antimicrobial resistance
Voß, A., & Ghafur, A. K. (2013) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-2-7 · Cited by 11
Faheem, M., Rehman, M. T., Danishuddin, M., & Khan, A. U. (2013) · PLoS ONE · doi:10.1371/annotation/049bf1aa-d866-471f-95c1-5939d4461f8c · Cited by 11
Self-citationNew antibiotics against bacterial resistance
Cárdenas, L. L., Merchán, M. A., & Velandia, D. P. L. (2019) · Infectio · doi:10.22354/in.v23i4.807 · Cited by 9
Repurposing CRISPR-Cas systems as DNA-based smart antimicrobials
Barrangou, R., & Ousterout, D. G. (2017) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2017.008 · Cited by 8
El-Lababidi, R. M., Atallah, B., & Abdel‐Razig, S. (2023) · International Medical Education · doi:10.3390/ime2010005 · Cited by 2
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Microfluidic systems for modeling digestive cancer: a review of recent progress
Razavi, Z., Soltani, M., Pazoki-Toroudi, H., & Dabagh, M. (2024) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ad6f15 · Cited by 24
Dermawan, D., & Alotaiq, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-93683-1 · Cited by 19
Metadata
- Authors
- Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2023-11-15
- Volume
- 16
- Issue
- 11
- Pages
- 1615
- ISSN
- 1424-8247 (ISSN-L)
- OpenAlex
- W4388699274
- Cited by
- 1,215
- References
- 243
- FWCI
- 34.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.